Iteos Therapeutics logo

Iteos Therapeutics Share Price Today

(NASDAQ: ITOS)

Iteos Therapeutics share price is $7.26 & ₹631.39 as on 6 Mar 2025, 2.30 'hrs' IST

$7.26

0.41

(5.99%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Iteos Therapeutics share price in Dollar and Rupees. Guide to invest in Iteos Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Iteos Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Iteos Therapeutics share price movements

  • Today's Low: $6.90
    Today's High: $7.37

    Day's Volatility :6.33%

  • 52 Weeks Low: $6.83
    52 Weeks High: $18.75

    52 Weeks Volatility :63.6%

Iteos Therapeutics (ITOS) Returns

PeriodIteos Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-14.27%
2.1%
0.0%
6 Months
-55.81%
-4.1%
0.0%
1 Year
-42.34%
2.2%
0.0%
3 Years
-80.51%
11.8%
-11.6%

Iteos Therapeutics (ITOS) Key Statistics

in dollars & INR

Previous Close
$6.85
Open
$6.84
Today's High
$7.365
Today's Low
$6.899
Market Capitalization
$255.4M
Today's Volume
$94.5K
52 Week High
$18.75
52 Week Low
$6.825
Revenue TTM
$35.0M
EBITDA
$-145.0M
Earnings Per Share (EPS)
$-3.14
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.89%
Return On Equity TTM
-19.72%

How to invest in Iteos Therapeutics Stock (ITOS) from India?

It is very easy for Indian residents to invest directly in Iteos Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iteos Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iteos Therapeutics or ITOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iteos Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iteos Therapeutics shares which would translate to 0.120 fractional shares of Iteos Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Iteos Therapeutics, in just a few clicks!

Returns in Iteos Therapeutics (ITOS) for Indian investors in Rupees

The Iteos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Iteos Therapeutics investment value today

Current value as on today

₹66,074

Returns

₹33,926

(-33.93%)

Returns from Iteos Therapeutics Stock

₹38,889 (-38.89%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Iteos Therapeutics (ITOS)

100%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Iteos Therapeutics Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Iteos Therapeutics

  • BlackRock Inc

    10.41%

  • Boxer Capital LLC

    8.07%

  • Mpm Asset Management, LLC

    7.50%

  • Bvf Inc

    6.36%

  • RA Capital Management, LLC

    5.73%

  • JPMorgan Chase & Co

    5.66%

Analyst Recommendation on Iteos Therapeutics

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Iteos Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Iteos Therapeutics Stock (ITOS)

What analysts predicted

Upside of 244.35%

Target:

$25.00

Current:

$7.26

Insights on Iteos Therapeutics Stock (Ticker Symbol: ITOS)

  • Price Movement

    In the last 6 months, ITOS stock has moved down by -55.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, -11.30M → 35.0M (in $), with an average increase of 132.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -7.12M → -45.35M (in $), with an average decrease of 536.3% per quarter
  • ITOS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 100.1%
  • ITOS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 127.4%
  • Price to Sales

    ForITOS every $1 of sales, investors are willing to pay $7.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Iteos Therapeutics Technicals Summary

Sell

Neutral

Buy

Iteos Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Iteos Therapeutics (ITOS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Iteos Therapeutics Inc logo
-8.42%
-55.81%
-42.34%
-80.51%
-64.04%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Iteos Therapeutics Inc logo
39.55
NA
NA
-3.15
-0.2
-0.13
NA
17.29
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Iteos Therapeutics Inc logo
Buy
$255.4M
-64.04%
39.55
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Iteos Therapeutics

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial, as well as used to engage the Fc gamma receptor, or Fc"R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonists that is in Phase 1/2a clinical trials to overcome the specific adenosine-mediated immunosuppression found in tumor microenvironment; and EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to inhibit the immunosuppressive activity of adenosine and restore immune cell proliferation is in Phase 1 clinical trials. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.
Organization
Iteos Therapeutics
Employees
157
CEO
Dr. Michel Detheux Ph.D.
Industry
Health Technology

Management People of Iteos Therapeutics

NameTitle
Dr. Michel Detheux Ph.D.
President, CEO & Director
Mr. Matthew Gall
Chief Financial Officer
Mr. Matthew A. Call M.B.A.
Chief Operating Officer
Dr. Yvonne McGrath Ph.D.
Chief Scientific Officer
Ms. Adi Osovsky
Executive Vice President of Legal
Mr. Philippe Brantegem
Executive Vice President of Human Resources
Dr. David Feltquate M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in ITOS Stock from India :

What is Iteos Therapeutics share price today?

Iteos Therapeutics share price today stands at $7.26, Open: $6.84 ; Previous Close: $6.85 ; High: $7.37 ; Low: $6.90 ; 52 Week High: $18.75 ; 52 Week Low: $6.83.

The stock opens at $6.84, after a previous close of $6.85. The stock reached a daily high of $7.37 and a low of $6.90, with a 52-week high of $18.75 and a 52-week low of $6.83.

Can Indians buy Iteos Therapeutics shares?

Yes, Indians can invest in the Iteos Therapeutics (ITOS) from India.

With INDmoney, you can buy Iteos Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Iteos Therapeutics at zero transaction cost.

How can I buy Iteos Therapeutics shares from India?

It is very easy to buy Iteos Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iteos Therapeutics (ITOS) be purchased?

Yes, you can buy fractional shares of Iteos Therapeutics with INDmoney app.

What are the documents required to start investing in Iteos Therapeutics stocks?

To start investing in Iteos Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Iteos Therapeutics Stock (ITOS)?

Today’s highest price of Iteos Therapeutics (ITOS) is $7.37.

Today’s lowest price of Iteos Therapeutics (ITOS) is $6.90.

What is today's market capitalisation of Iteos Therapeutics?

Today's market capitalisation of Iteos Therapeutics ITOS is 255.4M

What is the 52 Week High and Low Range of Iteos Therapeutics Stock (ITOS)?

  • 52 Week High

    $18.75

  • 52 Week Low

    $6.83

What are the historical returns of Iteos Therapeutics (ITOS)?

  • 1 Month Returns

    -8.42%

  • 3 Months Returns

    -55.81%

  • 1 Year Returns

    -42.34%

  • 5 Years Returns

    -64.04%

Who is the Chief Executive Officer (CEO) of Iteos Therapeutics ?

Dr. Michel Detheux Ph.D. is the current Chief Executive Officer (CEO) of Iteos Therapeutics.